Dmitri Wiederschain
Nessuna posizione attualmente
Profilo
Dmitri Wiederschain worked as the Chief Scientific Officer at Jounce Therapeutics, Inc. and as the VP & Global Head-Immuno Oncology Research at Sanofi.
He received his undergraduate and doctorate degrees from Harvard University.
Precedenti posizioni note di Dmitri Wiederschain
| Società | Posizione | Fine |
|---|---|---|
| SANOFI | Corporate Officer/Principal | - |
| JOUNCE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Dmitri Wiederschain
| Harvard University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SANOFI | Health Technology |
| Aziende private | 1 |
|---|---|
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- Dmitri Wiederschain
